Russell Steven Jon 4
4 · Beta Bionics, Inc. · Filed Feb 3, 2025
Insider Transaction Report
Form 4
Russell Steven Jon
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-01-31+53,584→ 53,584 totalExercise: $5.10Exp: 2033-09-13→ Common Stock (53,584 underlying) - Award
Employee Stock Option (right to buy)
2025-01-31+90,637→ 90,637 totalExercise: $17.00Exp: 2035-01-28→ Common Stock (90,637 underlying) - Award
Employee Stock Option (right to buy)
2025-01-31+81,217→ 81,217 totalExercise: $7.51Exp: 2032-12-14→ Common Stock (81,217 underlying)
Footnotes (4)
- [F1]One-fourth of the shares subject to this option shall vest one year after November 14, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.
- [F2]Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.
- [F3]The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.
- [F4]Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts.